Cargando…

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir

Detalles Bibliográficos
Autores principales:	Bafna, Khushboo, White, Kris, Harish, Balasubramanian, Royer, Catherine A., Garcia-Sastre, Adolfo, Krug, Robert M., Montelione, Gaetano T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Biophysical Society 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879802/ http://dx.doi.org/10.1016/j.bpj.2020.11.1950

Ejemplares similares

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
por: Bafna, Khushboo, et al.
Publicado: (2021)

Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
por: Greene-Cramer, Rebecca, et al.
Publicado: (2022)

Structural Similarity of SARS-CoV2 M(pro) and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics
por: Bafna, Khushboo, et al.
Publicado: (2020)

Structural similarities between SARS-CoV2 3CL(pro) and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals
por: Bafna, Khushboo, et al.
Publicado: (2022)

The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
por: Kwo, Paul Y., et al.
Publicado: (2011)

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro
por: Gammeltoft, Karen A., et al.
Publicado: (2021)

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
por: Pelliccia, Sveva, et al.
Publicado: (2017)

Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
por: Tchesnokov, Egor P., et al.
Publicado: (2019)

Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
por: Bringas, Mauro, et al.
Publicado: (2022)

Influenza virus polymerase inhibitors in clinical development
por: Hayden, Frederick G., et al.
Publicado: (2019)

Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation
por: Boff, Laurita, et al.
Publicado: (2020)

Protocol for production and purification of SARS-CoV-2 3CL(pro)
por: Mazzei, Luca, et al.
Publicado: (2023)

Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
por: Cai, Lei, et al.
Publicado: (2017)

Protease inhibitors for the treatment of hepatitis C virus infection
por: de Leuw, Philipp, et al.
Publicado: (2017)

Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase
por: Westera, Liset, et al.
Publicado: (2019)

A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase
por: Yuan, Shuofeng, et al.
Publicado: (2016)

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
por: Eltahla, Auda A., et al.
Publicado: (2015)

Identification of covalent active site inhibitors of dengue virus protease
por: Koh-Stenta, Xiaoying, et al.
Publicado: (2015)

Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
por: Lo, Michael K., et al.
Publicado: (2020)

A Spider-Derived Kunitz-Type Serine Protease Inhibitor That Acts as a Plasmin Inhibitor and an Elastase Inhibitor
por: Wan, Hu, et al.
Publicado: (2013)

Synergistic Inhibitor Binding to the Papain‐Like Protease of Human SARS Coronavirus: Mechanistic and Inhibitor Design Implications
por: Lee, Hyun, et al.
Publicado: (2013)

Antifibrinolytic Role of a Bee Venom Serine Protease Inhibitor That Acts as a Plasmin Inhibitor
por: Choo, Young Moo, et al.
Publicado: (2012)

Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
por: Zhang, Ruxue, et al.
Publicado: (2022)

Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
por: Meng, Xin, et al.
Publicado: (2021)

Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement
por: Said, Mohamed A., et al.
Publicado: (2022)

Allosteric Inhibitors of the NS3 Protease from the Hepatitis C Virus
por: Abian, Olga, et al.
Publicado: (2013)

In vitro study of Hesperetin and Hesperidin as inhibitors of zika and chikungunya virus proteases
por: Eberle, Raphael J., et al.
Publicado: (2021)

Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design
por: Li, Qingxin, et al.
Publicado: (2021)

Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose
por: LeCher, Julia C., et al.
Publicado: (2019)

Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro
por: Cao, Zeyu, et al.
Publicado: (2016)

Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase
por: Deval, Jerome, et al.
Publicado: (2016)

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors
por: Uddin, Reaz, et al.
Publicado: (2022)

Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
por: Zeminian, Luciana Bonome, et al.
Publicado: (2013)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus
por: Feng, Joy Y., et al.
Publicado: (2016)

Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
por: Bello-Pérez, Melissa, et al.
Publicado: (2018)

Discovery of Beclabuvir: A Potent Allosteric Inhibitor of the Hepatitis C Virus Polymerase
por: Gentles, Robert G.
Publicado: (2018)

Metabolic abnormalities in human immunodeficiency virus patients with protease inhibitor-based therapy
por: Ete, Tumnyak, et al.
Publicado: (2014)

X Protein of Hepatitis B Virus Resembles a Serine Protease Inhibitor
por: Takada, Shinako, et al.
Publicado: (1990)

High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses
por: Cihlova, Bara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lspee4o4mgrug5jpuvqvdg1lrs